1
|
Collinge M, Neff-LaFord H, Akella S, Fogal B, Fraser K, Jabbour J, Harper K, Maier CC, Malherbe L, Marshall N, Rao GK, Raman K, Skaggs H, Weber F, Fuller CL. Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey. Regul Toxicol Pharmacol 2024; 150:105630. [PMID: 38642729 DOI: 10.1016/j.yrtph.2024.105630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 03/15/2024] [Accepted: 04/17/2024] [Indexed: 04/22/2024]
Abstract
Immunotoxicology/immunosafety science is rapidly evolving, with novel modalities and immuno-oncology among the primary drivers of new tools and technologies. The Immunosafety Working Group of IQ/DruSafe sought to better understand some of the key challenges in immunosafety evaluation, gaps in the science, and current limitations in methods and data interpretation. A survey was developed to provide a baseline understanding of the needs and challenges faced in immunosafety assessments, the tools currently being applied across the industry, and the impact of feedback received from regulatory agencies. This survey also focused on current practices and challenges in conducting the T-cell-dependent antibody response (TDAR) and the cytokine release assay (CRA). Respondents indicated that ICH S8 guidance was insufficient for the current needs of the industry portfolio of immunomodulators and novel modalities and should be updated. Other challenges/gaps identified included translation of nonclinical immunosafety assessments to the clinic, and lack of relevant nonclinical species and models in some cases. Key areas of emerging science that will add future value to immunotoxicity assessments include development of additional in vitro and microphysiological system models, as well as application of humanized mouse models. Efforts are ongoing in individual companies and consortia to address some of these gaps and emerging science.
Collapse
Affiliation(s)
| | | | - Surekha Akella
- Abbvie Biotherapeutics Inc., South San Francisco, CA, USA
| | | | | | | | | | | | | | | | | | | | | | - Felix Weber
- F. Hoffmann-La Roche Ltd., Basel, Switzerland
| | | |
Collapse
|
2
|
Skaggs H, Chellman GJ, Collinge M, Enright B, Fuller CL, Krayer J, Sivaraman L, Weinbauer GF. Comparison of immune system development in nonclinical species and humans: Closing information gaps for immunotoxicity testing and human translatability. Reprod Toxicol 2019; 89:178-188. [PMID: 31233776 DOI: 10.1016/j.reprotox.2019.06.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2019] [Revised: 05/13/2019] [Accepted: 06/12/2019] [Indexed: 02/07/2023]
Affiliation(s)
- H Skaggs
- Incyte Corporation, Wilmington, DE, USA.
| | | | - M Collinge
- Pfizer Worldwide Research and Development, Groton, CT, USA
| | | | - C L Fuller
- Merck and Co., Safety Assessment and Laboratory Animal Resources, West Point, PA, USA
| | - J Krayer
- Janssen Research & Development, Nonclinical Safety, Spring House, PA, USA
| | - L Sivaraman
- Bristol-Myers Squibb Company, Research & Development, New Brunswick, New Jersey, USA
| | - G F Weinbauer
- Covance Preclinical Services GmbH, Muenster, Germany
| |
Collapse
|
3
|
Descotes J, Allais L, Ancian P, Pedersen HD, Friry-Santini C, Iglesias A, Rubic-Schneider T, Skaggs H, Vestbjerg P. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative. Regul Toxicol Pharmacol 2018; 94:271-275. [PMID: 29481836 DOI: 10.1016/j.yrtph.2018.02.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2017] [Revised: 02/05/2018] [Accepted: 02/22/2018] [Indexed: 02/06/2023]
Abstract
There is a growing need to consider non-rodent species for the immunological safety evaluation of drug candidates. The EU Framework-6 RETHINK Project demonstrated that the Göttingen Minipig is a relevant animal model for regulatory toxicology studies. Extensive knowledge on the immune system of domestic pigs is available and fewer differences from humans have been identified as compared to other species, such as mice or non-human primates. Minipig data are too scarce to allow for claiming full immunological comparability with domestic pigs. Another gap limiting minipig use for immunological safety evaluation is the lack of a qualified and validated database. However, available data lend support to the use of minipigs. The need for a COllaborative Network For Immunological safety Research in Minipigs (the CONFIRM Initiative) was obvious. It is intended to trigger immunological safety research in Göttingen Minipigs, to assist and synergize fundamental, translational and regulatory investigative efforts relevant to the immunological safety evaluation of pharmaceuticals and biologics, and to spread current knowledge and new findings to the scientific and regulatory toxicology community.
Collapse
Affiliation(s)
- Jacques Descotes
- ImmunoSafe Consulting & University of Lyon, 38480 Saint Jean d'Avelanne, France.
| | - Linda Allais
- Charles River Laboratories, 69210 Saint Germain-Nuelles, France
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Selden N, Skaggs H, Lowe T, Haycock K, Dinh V. 338 Assessing the Utility of Nursing-Performed Point-of-Care Ultrasound as a Guide to Fluid Resuscitation of Septic Patients in the Emergency Department. Ann Emerg Med 2017. [DOI: 10.1016/j.annemergmed.2017.07.409] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Otieno MA, Snoeys J, Lam W, Ghosh A, Player MR, Pocai A, Salter R, Simic D, Skaggs H, Singh B, Lim HK. Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury. Toxicol Sci 2017; 163:374-384. [DOI: 10.1093/toxsci/kfx040] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Affiliation(s)
- Monicah A Otieno
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Jan Snoeys
- Preclinical Development & Safety, Janssen Pharmaceutica NV, Beerse, Antwerpen BE 2340, Belgium
| | - Wing Lam
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Avi Ghosh
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Mark R Player
- Cardiovascular & Metabolism, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Alessandro Pocai
- Cardiovascular & Metabolism, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Rhys Salter
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Damir Simic
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Hollie Skaggs
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Bhanu Singh
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| | - Heng-Keang Lim
- Preclinical Development and Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania 19477
| |
Collapse
|
6
|
Abstract
Vehicle control Harlan RCCHan™: WIST rats were examined to provide control data for subsequent studies. Sixty male and 60 female rats were sacrificed after 4, 13, and 26 weeks (360 animals total) of daily oral gavage dosing with reverse osmosis water. At necropsy, body weights, organ weights, and macroscopic findings were recorded, and tissues were collected for histopathology. Mean terminal body and organ weight data demonstrated expected age-related trends. Macroscopic findings occurred sporadically, generally at singular or at very low incidence, and with no observable age-related trend. The most frequent observation was discoloration of the stomach mucosa. Neoplastic microscopic findings were uncommon (one endometrial stromal polyp; one hepatocellular adenoma; one C-cell adenoma; and one sarcoma, NOS). The most common and/or notable nonneoplastic microscopic findings included basophilic tubules and mononuclear cell infiltration in the kidney, macrophage infiltration in pulmonary alveoli, and mononuclear infiltration in the liver of males and females, and myocardial degeneration/necrosis and mononuclear cell infiltration in the heart of males. Female reproductive tracts were staged to establish a representative baseline distribution. Diestrus, proestrus, estrus, and metestrus were diagnosed 45.8%, 11.9%, 30.5%, and 11.9%, respectively, at 4 weeks and 27.6%, 13.8%, 50.0%, and 8.6%, respectively, at 13 weeks.
Collapse
|
7
|
Woodward JG, Murapa P, Gandhapudi S, Skaggs H, Sarge K. HSF1 is necessary for reactive oxygen species (ROS) homeostasis and proliferation in T cells at fever temperatures. (87.47). The Journal of Immunology 2007. [DOI: 10.4049/jimmunol.178.supp.87.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Abstract
HSF1 is a major heat and stress inducible transcription factor in eukaryotic cells responsible for the regulation of a variety of genes involved in maintenance of cellular homeostasis. We have previously shown that HSF1 is activated at physiologic fever temperatures (39oC) in T cells vs. much higher, non-physiologic temperatures (42oC) in most other cell types. T cells from HSF1−/− mice proliferate normally at 37oC, but are severely inhibited at 39oC. These T cells are blocked at the G1-S phase transition of the cell cycle. T cells normally increase ROS levels as a result of activation. Antioxidants which block ROS increases also inhibit proliferation. We found that fever temperatures also inhibited the normal activation induced increase of ROS in T cells within 2h. Wild type T cells can overcome this inhibition in ROS generation within 5h and go on to proliferate normally. In contrast, HSF1−/− T cells were unable to overcome this dysregulation and failed to proliferate. Thus, fever temperature causes a dysregulation in ROS homeostasis in T cells and HSF1 is critical in restoring this regulation.
Collapse
Affiliation(s)
| | | | | | - Hollie Skaggs
- 2Cellular and Molecular Biochemistry, University of Kentucky, Medical Center, MN426, 800 Rose St, Lexington, KY, 40536
| | - Kevin Sarge
- 2Cellular and Molecular Biochemistry, University of Kentucky, Medical Center, MN426, 800 Rose St, Lexington, KY, 40536
| |
Collapse
|
8
|
Wilkerson D, Skaggs H, Sarge K. HSF2 Binds to the Hsp90, Hsp27, and c-Fos Promoters Constitutively and Modulates their Expression. Cell Stress Chaperones 2005. [DOI: 10.1379/csc-250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
9
|
Powell DA, Skaggs H, Churchwell J, McLaughlin J. Posttraining lesions of the medial prefrontal cortex impair performance of Pavlovian eyeblink conditioning but have no effect on concomitant heart rate changes in rabbits (Oryctolagus cuniculus). Behav Neurosci 2002. [PMID: 11584915 DOI: 10.1037//0735-7044.115.5.1029] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The medial prefrontal cortex (mPFC) plays a critical role in conditioned autonomic adjustments but is not involved in classically conditioned somatomotor responses unless the training conditions include reversal or trace conditioning. The studies showing these effects have all used pretraining lesions. The present study assessed the effects of posttraining lesions on eyeblink (EB) and heart rate (HR) conditioned responses (CRs) in both delay and trace conditioning paradigms in the rabbit (Oryctolagus cuniculus). Posttraining lesions lowered the percentage of EB CRs during retesting compared with pretesting levels for both delay and trace conditioning. Control lesions and pretraining lesions produced no significant effects during retesting. Posttraining lesions had no effect on the HR CR. These findings suggest that a critical mechanism in the mPFC is involved in retrieval of information during EB conditioning but that the mPFC integration of autonomic and somatomotor processes is not critical to this retrieval process.
Collapse
Affiliation(s)
- D A Powell
- Neuroscience Laboratory, Veterans Affairs Medical Center, Columbia, South Carolina 29209-1639, USA.
| | | | | | | |
Collapse
|
10
|
Powell DA, Skaggs H, Churchwell J, McLaughlin J. Posttraining lesions of the medial prefrontal cortex impair performance of Pavlovian eyeblink conditioning but have no effect on concomitant heart rate changes in rabbits (Oryctolagus cuniculus). Behav Neurosci 2001; 115:1029-38. [PMID: 11584915 DOI: 10.1037/0735-7044.115.5.1029] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The medial prefrontal cortex (mPFC) plays a critical role in conditioned autonomic adjustments but is not involved in classically conditioned somatomotor responses unless the training conditions include reversal or trace conditioning. The studies showing these effects have all used pretraining lesions. The present study assessed the effects of posttraining lesions on eyeblink (EB) and heart rate (HR) conditioned responses (CRs) in both delay and trace conditioning paradigms in the rabbit (Oryctolagus cuniculus). Posttraining lesions lowered the percentage of EB CRs during retesting compared with pretesting levels for both delay and trace conditioning. Control lesions and pretraining lesions produced no significant effects during retesting. Posttraining lesions had no effect on the HR CR. These findings suggest that a critical mechanism in the mPFC is involved in retrieval of information during EB conditioning but that the mPFC integration of autonomic and somatomotor processes is not critical to this retrieval process.
Collapse
Affiliation(s)
- D A Powell
- Neuroscience Laboratory, Veterans Affairs Medical Center, Columbia, South Carolina 29209-1639, USA.
| | | | | | | |
Collapse
|
11
|
Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265:2831-5. [PMID: 1851894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Sumatriptan succinate, a 5-HT1D receptor agonist, constricts human cranial arteries. Two parallel-group trials for treatment of acute migraines were conducted in the United States. Adult patients were randomized and given either 6 mg of sumatriptan succinate subcutaneously (n = 734) or placebo (n = 370). At 1 hour, sumatriptan was significantly more effective than placebo in reducing moderate or severe headache pain to mild or no pain (70% vs 22%), in completely relieving headaches (49% vs 9%), and in improving clinical disability (76% vs 34%). Sumatriptan also reduced nausea and photophobia significantly better than placebo. Patients with residual migraines received another injection; those who had originally received sumatriptan received either a second active injection (n = 187) or placebo (n = 178), while those who had received placebo received a second placebo injection (n = 335). Statistical evidence for benefit of second sumatriptan injection is absent. Adverse events associated with sumatriptan were tingling, dizziness, warm-hot sensations, and injection-site reactions. Sumatriptan is effective and well tolerated in patients with acute migraine.
Collapse
Affiliation(s)
- R K Cady
- Shealy Institute for Comprehensive Health Care, Springfield, Mo. 65803
| | | | | | | | | | | |
Collapse
|
12
|
Skaggs H. Computed tomography in stroke. Prim Care 1980; 7:3-12. [PMID: 6901183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Computed tomography, an important part of the evaluation of patients with stroke, is particularly useful in distinguishing hemorrhage from infarction and in localizing lesions of the posterior fossa. A CT scan is not needed in every patient, but should be used in acute illness and when the clinical picture is not clear.
Collapse
|
13
|
|